| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/21/2007 | CN1305469C Use of levo-ornidazole for preparing anti-parasitic-infectious drug |
| 03/21/2007 | CN1305467C Zinc containing compositions for anti-viral use |
| 03/21/2007 | CN1305464C Temperature-reducing refreshing aerosol |
| 03/21/2007 | CN1305463C Ginseng and aconite spraying agent for treating qi vacuity and yang desertion and its preparation method |
| 03/21/2007 | CN1305462C Diffusional implantable delivery system |
| 03/20/2007 | US7193084 Crystal structure determined by differential scanning calorimetry and infrared analysis |
| 03/20/2007 | US7192942 Wet milling while crystallizing to obtain a primary particle suspension. |
| 03/20/2007 | US7192941 Estradiol metabolites for the treatment of pulmonary hypertension |
| 03/20/2007 | US7192938 Orally administered risedronic acid or salt for osteoporosis or bone disorder treatment |
| 03/20/2007 | US7192919 Insoluble, amorphous complex comprising insulin and zinc, is in aerosolized form for treating diabetes; administering to the lung through inhalation; a salt formation of insulin and zinc chloride; new chemical derivative of existing drug |
| 03/20/2007 | US7192693 Methods for photopatterning hydrogels |
| 03/20/2007 | US7192614 Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
| 03/20/2007 | US7192612 Prophylaxis, prevention, therapy for cancer |
| 03/20/2007 | US7192608 Coating water soluble drug; high density active materials; uniform, stable |
| 03/20/2007 | US7192607 Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention, and an applicator for the delivery of topical formulations into mucosal cavities |
| 03/20/2007 | US7192606 carbocyclic imidodisulfamide compounds; preferably but not limited to infections caused by orthopox viruses |
| 03/20/2007 | US7192605 Composition for use in the efficient transfer of nucloetide sequences into cells |
| 03/20/2007 | US7192604 Tissue scaffolds which facilitate tissue infiltration there through for repair or regeneration of diseased or damaged musculoskeletal tissue, wherein first type of fibers biodegrade faster than second |
| 03/20/2007 | US7192599 Mattifying oil-in-water emulsion |
| 03/20/2007 | US7192597 comprising fatty compound, quaternary ammonium compound and S-adenosylmethionine |
| 03/20/2007 | US7192592 administering protein comprising a first polypeptide disulfide-bonded to a second polpeptide, wherein each of said first and second polypeptides comprises amino acid residues 258 to 370 of SEQ ID NO:2 and wherein said protein is mitogenic or chemotactic for mesenchymal cells |
| 03/20/2007 | US7192588 Stable compressed or hard tableted vaccine composition comprising at least one lyophilized antigenic component and a dissolution aid |
| 03/20/2007 | US7192575 Antimicrobial composition |
| 03/20/2007 | US7192546 Mixing metal or ceramic powder, drugs with polymer; heating to crosslink, solidification, molding |
| 03/20/2007 | US7192542 Oil absorbing composition and process |
| 03/20/2007 | US7192414 Programmable implantable pump with accessory reservoirs and multiple independent lumen catheter |
| 03/20/2007 | US7192308 Coaxial connector having detachable locking sleeve |
| 03/20/2007 | CA2438768C Improved flexible collodion compositions |
| 03/20/2007 | CA2411787C Stable gabapentin having ph within a controlled range |
| 03/20/2007 | CA2364845C Extending the duration of drug release within the stomach during the fed mode |
| 03/20/2007 | CA2360655C Pharmaceutical compositions |
| 03/20/2007 | CA2350696C Improved uncomplexed cyclodextrin compositions for odor control |
| 03/20/2007 | CA2337047C Method of obscuring immune recognition |
| 03/20/2007 | CA2315115C Compositions of microspheres for wound healing |
| 03/15/2007 | WO2007030545A2 Biodegradable microparticle pharmaceutical formulations exhibiting improved release rates |
| 03/15/2007 | WO2007030537A1 Topical formulations containing o-desmethyl venlafaxine (odv) or its salts |
| 03/15/2007 | WO2007030117A2 Multifunctional self-decontaminating surface coating |
| 03/15/2007 | WO2007030108A1 Vitamin b-12 compositions |
| 03/15/2007 | WO2007029781A1 Adhesive preparation containing bisoprolol |
| 03/15/2007 | WO2007029660A1 Microparticle of hardly-soluble substance having enteric base material adsorbed on the surface of the substance |
| 03/15/2007 | WO2007029376A1 Orally rapidly disintegrating tablet |
| 03/15/2007 | WO2007029361A1 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same |
| 03/15/2007 | WO2007029345A1 Tyrosinase activity inhibitor |
| 03/15/2007 | WO2007029340A1 Method of using aloe powder in sexual intercourse as lubricant having lubricity |
| 03/15/2007 | WO2007029198A2 Sanitary napkins with hydrophobic lotions |
| 03/15/2007 | WO2007029098A1 Liquid filled delivery system, preferably an hpmc capsule filled with glycerol |
| 03/15/2007 | WO2007029087A2 Controlled release multiple unit formulations |
| 03/15/2007 | WO2007029081A1 Galantamine-containing controlled release oral dosage forms, processes for the preparation thereof and use for the manufacture of a medicament |
| 03/15/2007 | WO2007029070A1 Extended release composition of meteprolol succinate |
| 03/15/2007 | WO2007028984A1 Apparatus and method for sonoporation |
| 03/15/2007 | WO2007028981A1 Apparatus and method for sonoporation |
| 03/15/2007 | WO2007028978A2 Ramipril formulation |
| 03/15/2007 | WO2007028788A1 New use for a composition comprising chloroprocaine hcl, a new composition comprising chloroprocaine hcl and a method for its manufacture |
| 03/15/2007 | WO2007028513A2 Application system for a plaster containing an active ingredient and a controlled-release agent for said active ingredient |
| 03/15/2007 | WO2007028341A1 Nano anticancer micelles of vinca alkaloids entrapped in polyethylene glycolylated phospholipids |
| 03/15/2007 | WO2007028247A1 Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
| 03/15/2007 | WO2007001979A3 Medicament delivery article, accessory & system |
| 03/15/2007 | WO2006135638A3 Tanaproget compositions containing ethinyl estradiol |
| 03/15/2007 | WO2006131401A3 Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent |
| 03/15/2007 | WO2006127284A3 Method of purifying apo-2 ligand/trail using crystallisation in the cold |
| 03/15/2007 | WO2006122330A3 Implantable pump with infinitely variable resistor |
| 03/15/2007 | WO2006121560A3 Methods and compositions for treatment of cns disorders |
| 03/15/2007 | WO2006119968A3 Compositions and methods using microspheres and non-ionic contrast agents |
| 03/15/2007 | WO2006115690A3 Production of emulsions for intravenous injection of water-insoluble pharmaceutical compositions |
| 03/15/2007 | WO2006105196A3 Diindolylmethane-based compositions and methods of use thereof for promoting oral mucosal and bone health |
| 03/15/2007 | WO2006104760A3 OPHTHALMIC COMPOSITIONS COMPRISING dDC |
| 03/15/2007 | WO2006100692A3 A novel inter and intra multilamellar vesicular composition. |
| 03/15/2007 | WO2006091180A3 Fucoidan multiparticulate drug carrier systems |
| 03/15/2007 | WO2006084140B1 Method for reducing the level of peroxides in bopcompatible polymer preparations |
| 03/15/2007 | WO2006084083A3 Devices for delivering agents to a vaginal tract |
| 03/15/2007 | WO2006055659A3 Fixed dose combination op dutasteride and tamsulosin |
| 03/15/2007 | WO2006040085A3 Bilayer tablet |
| 03/15/2007 | WO2006035416A3 Minicapsule formulations |
| 03/15/2007 | WO2005110358A3 Film-shaped estriol-containing medicament for oral administration |
| 03/15/2007 | WO2005044186A3 Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same |
| 03/15/2007 | WO2003068169A3 Stabilized synthetic immunogen delivery system |
| 03/15/2007 | US20070060906 Method, reagent, and device for embolizing blood vessels in tumors with ultrasonic radiation micro-bubble reagent |
| 03/15/2007 | US20070060805 Optical sampling interface system for in vivo measurement of tissue |
| 03/15/2007 | US20070060648 Lipids from methanotrophic bacteria for cholesterol reduction |
| 03/15/2007 | US20070060636 High enantiomeric purity dexanabinol for pharmaceutical compositions |
| 03/15/2007 | US20070060635 Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
| 03/15/2007 | US20070060627 Organic compounds |
| 03/15/2007 | US20070060621 Methods and compositions for the administration of prodrugs of proton pump inhibitors |
| 03/15/2007 | US20070060610 Methods and pharmaceutical formulations for increasing bioavailability |
| 03/15/2007 | US20070060544 4-Nitro-2-[(4'-methoxy)-phenoxy]-methanesulfonanilide derivatives and their pharmaceutical use |
| 03/15/2007 | US20070060541 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060538 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 03/15/2007 | US20070060511 Combinations of immunosupressive agents for the treatment or prevention of graft rejections |
| 03/15/2007 | US20070060509 Endoparasiticidal compositions for topical application |
| 03/15/2007 | US20070060505 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060504 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060503 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 03/15/2007 | US20070060498 2' and 3'-Prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides provide superior results against flaviviruses and pestiviruses, including hepatitis C virus and viruses that replicate through an RNA dependent RNA reverse transcriptase; administering interferons as second antivirus agent |
| 03/15/2007 | US20070059799 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 03/15/2007 | US20070059681 Method for production of bioresorable microparticles, microparticles thus obtained and use thereof |
| 03/15/2007 | US20070059454 Products for treating and preventing chronic diseases: eliminating the autoimmune triggers that underly chronic disease |
| 03/15/2007 | US20070059435 Stent with drug coating |
| 03/15/2007 | US20070059381 Treatment of amd with combination of ingredients |
| 03/15/2007 | US20070059376 Peptide conjugate |
| 03/15/2007 | US20070059375 Tissue engineering by injecting spherical porous particles as bulking material into tissue to constrict and narrow a physiological passageway by using crosslinked polyvinyl alcohol having gradient of pore sizes; vesicoureteral reflux; gastroesophageal reflux disease; urinary/fecal incontinance |